Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…
BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed industrial hub of traditional Chinese medicine (TCM) for centuries, has actively…
BEIJING, Nov. 1, 2025 /PRNewswire/ -- Global Fine Wines & Spirits Declaration of Chishui River has been issued during the 2025…
BEIJING, Oct. 31, 2025 /PRNewswire/ -- The 2025 Overseas Promotion of the Charming Beijing TV series is a cultural exchange initiative…
The new Lancet Countdown China report reveals that 8 of 13 climate-health risk indicators are at historic peaks; the Beijing…
BEIJING, Oct. 31, 2025 /PRNewswire/ -- The 2025 Chishui River Forum was held in southwest China's Guizhou Province on Tuesday with…
BEIJING, Oct. 31, 2025 /PRNewswire/ -- Amid the wave of the digital economy, new-generation digital technologies such as cloud computing,…
BEIJING, Oct. 30, 2025 /PRNewswire/ -- The 2025 Chishui River Forum was held in Maotai Town of Renhuai City in southwest…
BEIJING, Oct. 28, 2025 /PRNewswire/ -- Quanzhou, a port city in southeast China's Fujian Province, is renowned for its long…
Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or the…